Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Toronto
$120,000.00
The Lifetime Management of Severe Aortic Stenosis in Patients Younger than 65 Years Old.
EF 2025-26
Résumé
Aortic stenosis is the narrowing of the heart's aortic valve. Aortic stenosis is the most common heart valve disease in Canada. Severe aortic stenosis is life-threatening: nearly half of the affected people die within two years. Open-heart surgery to replace the valve is the only option. There are different ways to replace the valve, but the best strategy in younger patients (adults who are 65 years old or under) remains a topic of considerable debate.
Younger patients with aortic stenosis are in a unique situation because they have longer life expectancy, and because of this, they have a higher likelihood of the new valve wearing out. A worn-out valve can only be treated with repeat surgery. We want to avoid repeat surgery because this has a very high risk of death and permanent stroke. Therefore, the best strategy for treating severe aortic stenosis in younger patients will need to be durable in the long term to avoid repeat surgery.
While there have been many randomised clinical trials on older patients (i.e., greater than 65 years old), the evidence for the most durable approach in younger patients (65 years old or younger) is lacking. It is also possible that the best strategy is different for biological females versus biological males because females tend to have smaller valve areas than males. Additionally, it is unclear if everyone has equitable access to these treatment strategies. Even with universal health care in Canada, there could still be inequitable access because of many factors, such as income status, race, and geographical area (e.g., if they live in an urban versus rural area).
Our project aims to identify the best treatment strategy for younger adults and to examine whether all Canadians have equitable access to these procedures. The results will inform guidelines and the need for policy interventions that ensure Canadian adults younger than 65 living with severe AS have access to the best life-saving interventions.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559707
Name
Servito Maria
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
The Lifetime Management of Severe Aortic Stenosis in Patients Younger than 65 Years Old.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Aortic Valve; Cardiac Surgery; Changepoint Analysis; Decision Analysis; Geographical Information System; Inverse Probability Treatment Weighting; Ontario Marginalization Index; Piecewise Linear Regression; Target Trial Emulation
Abstract
Aortic stenosis is the narrowing of the heart's aortic valve. Aortic stenosis is the most common heart valve disease in Canada. Severe aortic stenosis is life-threatening: nearly half of the affected people die within two years. Open-heart surgery to replace the valve is the only option. There are different ways to replace the valve, but the best strategy in younger patients (adults who are 65 years old or under) remains a topic of considerable debate.
Younger patients with aortic stenosis are in a unique situation because they have longer life expectancy, and because of this, they have a higher likelihood of the new valve wearing out. A worn-out valve can only be treated with repeat surgery. We want to avoid repeat surgery because this has a very high risk of death and permanent stroke. Therefore, the best strategy for treating severe aortic stenosis in younger patients will need to be durable in the long term to avoid repeat surgery.
While there have been many randomised clinical trials on older patients (i.e., greater than 65 years old), the evidence for the most durable approach in younger patients (65 years old or younger) is lacking. It is also possible that the best strategy is different for biological females versus biological males because females tend to have smaller valve areas than males. Additionally, it is unclear if everyone has equitable access to these treatment strategies. Even with universal health care in Canada, there could still be inequitable access because of many factors, such as income status, race, and geographical area (e.g., if they live in an urban versus rural area).
Our project aims to identify the best treatment strategy for younger adults and to examine whether all Canadians have equitable access to these procedures. The results will inform guidelines and the need for policy interventions that ensure Canadian adults younger than 65 living with severe AS have access to the best life-saving interventions.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Servito, Maria
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~